Topic Hub
42 clinically reviewed articles, written and peer-reviewed by the HealthRX Medical Team.
Explore
Showing 42 of 42 clinical reviews.
A clinician-reviewed guide to Anadrol (oxymetholone), covering its pharmacology, clinical uses, documented risks, and how it compares to investigational compounds like ostarine, LGD-4033, RAD-140, and cardarine.
Read clinical reviewA physician-reviewed guide to oxandrolone (Anavar): FDA-approved indications, evidence-based dosing for men and women, side effects, liver safety, and how it stacks up against SARMs like ostarine, LGD-4033, RAD-140, and cardarine.
Read clinical reviewA clinical comparison of Anavar (oxandrolone) vs Ostarine (MK-2866): mechanisms, body-composition data, side-effect profiles, legality, and which option fits your goals.
Read clinical reviewA physician-reviewed breakdown of andarine S-4 (S4), covering its mechanism, body-composition effects, side effects, legal status, and how it compares to ostarine, ligandrol, RAD-140, and cardarine.
Read clinical reviewSARMs are not FDA-approved, banned by WADA, and illegal to sell as dietary supplements in the US. This guide covers the law, muscle-building evidence, PCT requirements, drug testing, and safer alternatives.
Read clinical reviewA clinician-reviewed guide to body recomposition across populations: competitive athletes, recreational lifters, post-bariatric patients, older adults, and women. Includes specific protocols, trial data, and dosing frameworks.
Read clinical reviewA clinician-reviewed guide to body recomposition for recreational lifters, older adults, women, and post-bariatric patients. Covers protein targets, training variables, hormones, and evidence-based strategies backed by named trials.
Read clinical reviewA clinician-reviewed guide to body composition: what the four components are, which measurement methods are most accurate, and evidence-based strategies for losing fat and building muscle at the same time.
Read clinical reviewA clinician-reviewed guide to diagnosing and fixing a bulking plateau, covering progressive overload failures, protein targets, hormonal blockers, visceral fat accumulation, sarcopenia risk, and GLP-1 recomp strategies.
Read clinical reviewA clinician-reviewed guide to cachexia covering diagnostic criteria, muscle-wasting mechanisms, drug therapies, nutrition protocols, and how cachexia differs from sarcopenia and simple malnutrition.
Read clinical reviewMonthly DEXA scans are technically safe but rarely necessary. Learn the evidence-based schedule for body composition and bone density monitoring, when more frequent scanning adds value, and how to read your results.
Read clinical reviewA clinician-reviewed breakdown of cardarine GW-501516, covering its mechanism, the cancer findings that halted development, how it compares with ostarine, ligandrol, RAD-140, and stenabolic, and what FDA enforcement means for buyers.
Read clinical reviewClenbuterol causes arrhythmias, hypertension, and structural heart damage even at low doses. SARMs carry measurable liver toxicity and suppress the HPG axis in weeks. This clinical review covers mechanisms, documented cases, and safer alternatives.
Read clinical reviewA clinical review of clenbuterol's pharmacology, real-world risks, legal status, and how it compares to SARMs like Ostarine, Ligandrol, RAD 140, and Cardarine for body composition.
Read clinical reviewA detailed clinical comparison of clenbuterol and cardarine (GW501516) for fat loss and body composition, covering mechanisms, side effects, legal status, and safer alternatives. Reviewed by the HealthRX medical team.
Read clinical reviewA physician-reviewed breakdown of compounded oxandrolone (Anavar) pricing, dosing costs, legal status, and how it compares to SARMs. Includes real dose ranges, pharmacy tiers, and what drives price variation.
Read clinical reviewA clinical breakdown of SARMs pricing, legal status, compounded anavar costs, and safer prescription alternatives. Reviewed by the HealthRX medical team.
Read clinical reviewSARMs do produce measurable lean-mass gains in clinical trials, but the effect sizes are modest, the legal status is complicated, and the safety data are thin. Here is what the research actually says before you consider using one.
Read clinical reviewAnavar (oxandrolone) has a milder side-effect profile than most anabolic steroids, but 'safer' is relative. This evidence-based guide compares hepatotoxicity, cardiovascular risk, androgen suppression, and legal status across oxandrolone, testosterone, nandrolone, and SARMs.
Read clinical reviewCreatine monohydrate is the most evidence-backed legal supplement for muscle and strength, but how far does it actually take you without training, diet, or other interventions? A clinician-reviewed breakdown of what creatine does and doesn't do, how it compares to SARMs and anavar, and when a medical provider should be involved.
Read clinical reviewA physician-reviewed guide to L-carnitine injections covering mechanism, clinical evidence, dosing protocols, comparisons with SARMs like RAD-140 and LGD-4033, and who is a candidate for injectable carnitine therapy.
Read clinical reviewEvidence-based guide to LGD-4033 cycle length, dosing protocols, testosterone suppression data, and PCT requirements. Reviewed by the HealthRX medical team.
Read clinical reviewA physician-reviewed guide to ligandrol LGD-4033 covering clinical trial data, safety signals, FDA status, and how it compares with ostarine, RAD-140, cardarine, and stenabolic.
Read clinical reviewLoose skin after weight loss is caused by collagen breakdown, fat-cell deflation, and age-related elasticity loss. This evidence-based guide covers topical interventions, resistance training protocols, medical procedures, and when surgery is the right call.
Read clinical reviewA clinician-reviewed guide to body recomposition for older adults, covering protein targets, resistance training, GLP-1 medications, hormones, and post-bariatric considerations.
Read clinical reviewA clinician-reviewed guide to ostarine (MK-2866) dosing protocols, cycle lengths, LGD-4033 comparisons, and post-cycle therapy, with primary-source citations throughout.
Read clinical reviewA physician-reviewed breakdown of ostarine (MK-2866), covering clinical trial data, dosing, side effects, legal status, and how it compares to RAD 140, LGD-4033, cardarine, and SR9009.
Read clinical reviewA head-to-head clinical comparison of ostarine (MK-2866) and LGD-4033 (ligandrol): muscle gain, fat loss, suppression, side effects, and why neither is FDA-approved.
Read clinical reviewA physician-reviewed guide to post-cycle therapy after SARMs, covering which SARMs suppress the HPG axis, when PCT is necessary, clomiphene and nolvadex dosing, and how to confirm recovery with bloodwork.
Read clinical reviewA clinician-reviewed guide to optimizing body composition after bariatric surgery, covering protein targets, resistance training, hormonal changes, and evidence-based strategies for athletes, older adults, and women.
Read clinical reviewA detailed, physician-reviewed breakdown of RAD-140 (testolone), covering its mechanism, clinical evidence, side effects, legal status, and how it compares to ostarine, LGD-4033, cardarine, and SR9009.
Read clinical reviewStuck at the same weight and body composition for weeks? Learn the clinical reasons behind a recomp plateau, covering stubborn visceral fat, sarcopenia, and bulking stalls, plus evidence-based strategies to restart progress.
Read clinical reviewA clinician-reviewed guide to sarcopenia covering diagnostic criteria, muscle loss rates, resistance training protocols, protein targets, and GLP-1 considerations for lean mass preservation.
Read clinical reviewA clinical deep-dive into how SARMs suppress the hypothalamic-pituitary-gonadal axis, damage the liver, and stress the heart. Learn what the research actually says about dosing, recovery, and risk reduction.
Read clinical reviewSARMs cause drug-induced liver injury in documented case reports and FDA safety communications. Learn the mechanisms, warning signs, risk factors, and what safer alternatives exist.
Read clinical reviewA clinician-reviewed comparison of SARMs and anabolic steroids covering mechanism, efficacy, side-effect profiles, legality, and how specific compounds like ostarine, LGD-4033, and oxandrolone stack up on current evidence.
Read clinical reviewSR-9009 (Stenabolic) is a synthetic Rev-ErbA agonist sold as a SARM, but it is not a SARM and has never completed a human clinical trial. Learn what the animal data shows, what the FDA says, and what safer alternatives exist.
Read clinical reviewVisceral fat surrounds your organs, drives metabolic disease, and resists ordinary dieting. Learn what research says about measuring it, losing it, and why GLP-1s, strength training, and sleep matter more than crunches.
Read clinical reviewA physician-reviewed guide to body recomposition timelines: how long fat loss and muscle gain take simultaneously, what the research says, and when to consider hormonal support.
Read clinical reviewSARMs can be detected on specialized sports anti-doping panels but are missed by standard workplace urine screens. Learn which tests catch them, how long they stay in your system, and what the legal and health risks really are.
Read clinical reviewA clinician-reviewed guide to body recomposition for women: what the science says about simultaneous fat loss and muscle gain, optimized protocols for athletes, recreational lifters, post-bariatric patients, and older adults, with real trial data and dosing specifics.
Read clinical reviewA physician-reviewed breakdown of YK-11, covering its mechanism, the limited human safety data, legal status, and how it compares to ostarine, LGD-4033, RAD-140, and cardarine.
Read clinical review